Собственный капитал и резервы Изменить Дата
Akzo Nobel EUR 4.85B 28M 2026-06
Alcon AG USD 22.13B 99M 2026-03
AstraZeneca USD 50.3B 2.96B 2026-06
Bayer EUR 28.85B 2.9B 2026-03
Beiersdorf EUR 8.6B 133M 2025-12
DaVita Healthcare Partners USD -755.5M 104.41M 2026-03
Demant DKK 9.84B 446M 2025-12
E.ON EUR 28.83B 9.57B 2026-03
Essilor EUR 39.22B 329M 2026-06
Fresenius EUR 19.77B 1.14B 2025-12
Fresenius Medical Care EUR 14.2B 13.95B 2026-03
Genmab DKK 5.85B 96M 2025-12
Getinge SEK 30.94B 2.06B 2026-06
Givaudan CHF 4.54B 430M 2025-12
GlaxoSmithKline GBP 17.64B 223M 2026-06
GN Store Nord DKK 10.12B 4.76B 2026-03
GRIFOLS EUR 5.46B 171M 2026-03
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Lonza CHF 9.13B 513M 2025-12
Merck EUR 29.74B 1.15B 2026-03
Novartis USD 41.95B 3.02B 2026-06
Philips EUR 11.48B 84M 2026-06
Roche Holding CHF 32.69B 1.11B 2026-06
RWE EUR 41.56B 3.9B 2025-12
Sanofi EUR 72.81B 1.1B 2026-03
SAP EUR 44.74B 117M 2026-06
Smith & Nephew USD 5.54B 331M 2025-12